Most active stocks in Thursday's session
By Mill Chart
Last update: Sep 22, 2022
Let's have a look at the most active stocks in today's session.
Top most active stocks
| Ticker | Change | Comment |
|---|---|---|
| AVCT | 43.85% | 195.18M shares of AMERICAN VIRTUAL CLOUD TECHN (NASDAQ:AVCT) exchanged hands today. NASDAQ:AVCT is advancing 43.85% today. |
| SPRO | 172.0% | So far 192.45M shares of SPERO THERAPEUTICS INC (NASDAQ:SPRO) have traded in today's session. NASDAQ:SPRO is advancing 172.0% today. |
| AMD | -5.34% | ADVANCED MICRO DEVICES's (NASDAQ:AMD) traded a high volume of 56.95M shares. The share price decreased by 5.34%. |
| MULN | -7.98% | So far 55.44M shares of MULLEN AUTOMOTIVE INC (NASDAQ:MULN) have traded in today's session. Leading to a price decrease of 7.98%. |
| AAPL | -0.72% | 52.9M shares of APPLE INC (NASDAQ:AAPL) have been traded so far today. Leading to a price decrease of 0.72%. Yesterday the company had a press release: The Digital Camera Called iPhone 14 Pro Max At Shop Dunk. |
| NVDA | -5.25% | 50.59M shares of NVIDIA CORP (NASDAQ:NVDA) exchanged hands today. The share price decreased by 5.25%. |
| F | -0.96% | 49.95M shares of FORD MOTOR CO (NYSE:F) have been traded so far today. The share price decreased by 0.96%. A press release (Ford Announces Leadership Changes to Strengthen Product Creation and Transform Global Supply Chain Management) was released earlier today. |
| TSLA | -3.68% | 47.59M shares of TESLA INC (NASDAQ:TSLA) exchanged hands today. NASDAQ:TSLA is declining 3.68% today. |
| CCL | -0.67% | 45.96M shares of CARNIVAL CORP (NYSE:CCL) have been traded so far today. NYSE:CCL is declining 0.67% today. |
| MOHO | -39.18% | ECMOHO LTD's (NASDAQ:MOHO) traded a high volume of 44.44M shares. Leading to a price decrease of 39.18%. |
Our most active stocks screener will show you the full list.
SPERO THERAPEUTICS INC
NASDAQ:SPRO (4/24/2024, 10:00:53 AM)
1.42
-0.01 (-0.7%)
SPRO News
a month ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on ThursdayIt's time to start the day with a breakdown of all the biggest pre-market stock movers worth watching on Thursday morning!
On track for topline data from SPR720 Phase 2a proof-of-concept trial in treatment-naive and treatment-experienced non-refractory NTM-PD patients, expected...
CAMBRIDGE, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
CAMBRIDGE, Mass., Feb. 26, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical...
CAMBRIDGE, Mass., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company,...
In 2H 2024, expect to provide Phase 2a topline proof-of-concept data from our wholly-owned lead program SPR720 in NTM-PD patients
$95 million in development milestones payable over two years, as part of GSK license agreement...
6 months ago - Bragar Eagel & Squire, P.C.SPERO ALERT: Bragar Eagel & Squire, P.C. is Investigating Spero Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
